City tops polio vaccine refusal cases
Federal Health Minister Mustafa Kamal said on Sunday that his ministry had issued guidelines for the prevention of the polio virus across the country but emphasised that that eradication of the virus from environment was the responsibility of authorities working at grassroots levels.
Talking to media persons after chairing a meeting with the officials of anti-polio in Karachi, Kamal stated that the new phase of anti-polio campaign would commence from April 21. He urged the parents to get their children immunised against the polio virus for the healthy and better future of their children.
Kamal revealed that there were 44,000 polio vaccine refusal cases in the country, out of which 34,000 were in Karachi, including 27,000 in the city's East District alone. "Out of them, 15,000 refusals were reported from Urdu-speaking parents and 10,000 from Pashto speaking families in the city," he said.
Refuting the perception of polio vaccination's side or negative effects as rumours, he said that the anti-polio vaccination was totally safe and the parents should get their children vaccinated. He added that the vaccination was purchased by Unicef and it handed over by them to the government.
The new anti-polio vaccine was announced, as officials said that environmental surveillance detected wild poliovirus in sewage samples from 20 districts of the country, though the data suggested a decline in overall virus circulation.
According to the Regional Reference Laboratory for Polio Eradication at the National Institute of Health (NIH), 60 samples were collected from 51 districts. Of these, 25 tested positive for wild poliovirus type 1 (WPV1), while 35 others showed no presence of the virus.
The samples that confirmed the presence of WPV1 came from Dukki, Kech, Khuzdar, Lasbela, Loralai, Nasirabad, Pishin, Quetta, Usta Muhammad, Bannu, Kohat, Lakki Marwat, Peshawar, South Waziristan Lower, Bahawalpur, Bahawalnagar, Dera Ghazi Khan, Lahore, Multan, and Rahim Yar Khan districts.
Samples from Islamabad, Gilgit, Rawalpindi, Swat, Sahiwal, Nowshera, and others districts tested negative, pointing to improved control measures in several areas. "The trend shows a decline in positive samples and a reduction in virus circulation in many areas," an NIH official said.
Pakistan has reported only six polio cases so far in 2025, down from 74 in 2024. Officials credit improved immunisation drives since September last year. "Repeated vaccination strengthens immunity and helps stop the spread," the official added.
(WITH INPUTS FROM APP)
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Recorder
a day ago
- Business Recorder
Pakistan's vaccine independence: a national imperative
Pakistan stands at a critical crossroads in public health policy. With seven million births annually and a population growth rate of 2.55%, our nation faces an unprecedented challenge in vaccine security that demands immediate and decisive action. The looming withdrawal of GAVI support by 2031 presents not just a crisis, but an opportunity to transform Pakistan into a self-reliant pharmaceutical powerhouse. The stark reality we face The numbers paint a sobering picture of our current vulnerability. Pakistan's complete dependency on donated and discounted vaccine supplies, supported by GAVI, UNICEF, and WHO to the tune of PKR 26 billion annually, masks a deeper structural weakness. When GAVI's support ends in 2031, the financial burden will balloon to PKR 100 billion annually as nearly four times our current federal health budget of PKR 27 billion. This dependency is not merely financial; it represents a fundamental threat to national health security. This isn't just underdevelopment—it's a systematic surrender of national health autonomy. Today, Pakistan produces virtually no antigens for the Expanded Programme on Immunization (EPI) vaccines domestically. We lack essential seed banks, have minimal university-based vaccine development programs, and operate with regulatory guidelines that are inadequate for sophisticated vaccine manufacturing. Our clinical trial expertise remains severely limited, creating bottlenecks in bringing locally developed vaccines to market. The contrast with global pharmaceutical leaders is stark. While universities worldwide have been the birthplace of revolutionary vaccines-from the Hepatitis B vaccine developed at UC San Francisco to the Oxford-AstraZeneca Covid-19 vaccine-Pakistan's academic institutions remain largely disconnected from commercial vaccine production. Learning from global success stories International experience offers valuable lessons. India transformed itself into the 'pharmacy of the world' through strategic government support for generic manufacturing and robust regulatory frameworks. Singapore built a biomedical hub through integrated research, manufacturing, and regulatory excellence that attracted billions in global pharmaceutical investment. South Korea's government-industry partnerships created world-class biopharmaceutical capabilities. These success stories share common elements: sustained government commitment, strategic investment in infrastructure, regulatory excellence, and comprehensive talent development programs. Most importantly, they demonstrate that with the right approach, developing nations can achieve pharmaceutical self-sufficiency and even become global exporters. The Triple Helix solution The path forward requires unprecedented coordination between government, academia, and industry -what experts call the 'Triple Helix' approach. Each sector must play a distinct yet interconnected role in building national vaccine capacity. Government leadership is essential in creating policy frameworks that incentivize domestic production while providing funding for university research. Strategic assignments to national research institutions like the National Institute of Health, Centre of Excellence in Molecular Biology (CEMB), National Institute for Biotechnology and Genetic Engineering (NIBGE), International Centre for Chemical and Biological sciences (ICCBS), Karachi University, Department of Biotechnology, Dow University of Health Sciences (DUHS), etc., can accelerate vaccine development and establish crucial seed banks. Most critically, the government must develop a comprehensive national health security strategy that positions vaccine self-sufficiency as a matter of national defense. The regulatory transformation cannot be understated. Pakistan's Drug Regulatory Authority must achieve WHO Level 3 qualification and create 'regulatory sandboxes — collaborative environments where university researchers, industry partners, and regulatory experts jointly develop guidelines for the 13 critical EPI vaccine antigens. Fast-track approval pathways and clear regulatory roadmaps will accelerate the journey from laboratory research to commercial production. Formation of sandboxes by bringing together leaders of the University, Regulatory and Industry. Universities must step up as innovation engines. Institutions with BSL-III laboratories should lead development of live attenuated vaccines, while biotechnology departments focus on recombinant vaccine technologies. Specialized vaccine research centers, industry-relevant curricula, and technology transfer offices will bridge the gap between academic discovery and commercial application. State-of-the-art pilot manufacturing facilities will provide proof-of-concept capabilities essential for scaling innovations. Industry brings manufacturing excellence and market expertise to the equation. Private sector partners can transform academic research into GMP-compliant commercial production, establish robust supply chains for raw materials, and navigate complex regulatory approvals. Their distribution networks and market access capabilities will ensure that domestically produced vaccines reach every corner of Pakistan. Leading companies in Pakistan already in the field of Biopharmaceutical manufacturing must be involved in the development process. A realistic implementation roadmap Success requires a phased approach spanning six years. The foundation phase (Years 1-2) must establish policy frameworks and coordination mechanisms while launching capacity-building programmes. Infrastructure development (Years 2-4) involves scaling laboratory manufacturing capabilities, establishing vaccine testing facilities, and launching pilot production programs. The scale-up phase (Years 4-6) transitions to commercial production of EPI vaccines, regulatory approvals, and distribution network establishment. Finally, the optimization phase (Year 6+) expands manufacturing capabilities, develops advanced biologics production, and positions Pakistan as a regional pharmaceutical hub. Financial innovation will be crucial. Blended financing models combining public funding, private investment, and support from institutions like the Islamic Development Bank can mobilise the substantial capital required for drug substance manufacturing facilities. The initial investment may be significant, but the long-term savings and export potential far outweigh the costs. The economic and strategic imperative The benefits extend far beyond health security. A robust domestic vaccine industry could create over 5,000 jobs and reduce import dependency by 50 percent. More importantly, it would establish Pakistan as a regional pharmaceutical hub with significant export potential to neighboring countries and the broader Islamic world. The Covid-19 pandemic demonstrated the critical importance of pharmaceutical self-reliance. Nations with domestic production capabilities could respond rapidly to their populations' needs, while others waited months for external supplies. This lesson cannot be ignored as we face an uncertain global health landscape. The time for action is now Pakistan's demographic dividend — with 65 percent of the population under 30 — represents an unprecedented opportunity to build a knowledge-based pharmaceutical sector. However, this window will not remain open indefinitely. The GAVI deadline of 2031 provides a clear timeline for action, but preparation must begin immediately. The success of this transformation depends on political will, sustained investment, and most importantly, recognition that vaccine self-sufficiency is not a luxury but a national security imperative. Countries that fail to develop domestic pharmaceutical capabilities will remain perpetually vulnerable to supply disruptions, price volatility, and foreign policy pressures. A call to national action The establishment of National and Provincial Coordination Committees bringing together leaders from academia, industry, and regulatory agencies represents the essential first step. This must be followed by a comprehensive assessment of current capabilities, development of a detailed national vaccine strategy, and launch of pilot programmes for immediate impact. Pakistan has the intellectual capital, institutional foundation and market potential to achieve vaccine independence. What we need now is the collective will to transform this potential into reality. The health and prosperity of future generations depend on the decisions we make today. The choice is clear: remain dependent on the goodwill of international donors or invest in building a self-reliant pharmaceutical sector that serves not only Pakistan's needs but positions the nation as a leader in global health innovation. The Triple Helix approach offers a proven pathway to pharmaceutical independence-we must have the courage to take it. Copyright Business Recorder, 2025
Business Recorder
2 days ago
- Business Recorder
Safer, smarter healthcare services: Federal, Punjab Health ministries to launch joint initiatives
ISLAMABAD: The Federal Health Ministry and the Punjab Health department have decided to join hands for stronger, safer, and smarter healthcare services. The major development for national health collaboration came here on Thursday during a high-level meeting between Federal Minister for Health Mustafa Kamal and Punjab Minister for Primary and Secondary Healthcare Khawaja Imran Nazir. The meeting focused on strengthening coordination between the federal and provincial governments to address critical healthcare challenges and launch joint initiatives across key health areas. The meeting decided taking joint action against counterfeit medicines, coordinated efforts on polio eradication and dengue prevention and advancement of digital health systems and regulatory reform. The meeting was also attended by Special Secretary Health Syed Waqarul Hassan, Additional Secretary Health, Chief Information Officer of DRAP, Director General Health, and the President of the Pakistan Medical and Dental Council (PMDC),Dr Rizwan Taj. Kamal reiterated the federal government's resolve to address healthcare issues with urgency. He stated that under the direction of the prime minister, particular focus is being placed on eliminating polio and ensuring timely implementation of health programmes. 'The fight against polio continues with full zeal, until the virus is eliminated, our children remain at risk,' he emphasised. He shared plans for a new national strategy for polio eradication and urged parents to disregard negative propaganda and ensure their children are vaccinated. 'In Palestine, even during war, mothers call for vaccinators with whistles. Pakistani mothers must also play their part in protecting their children,' he said. Kamal highlighted steps being taken by DRAP to combat counterfeit medicines, including the rollout of a modern barcode system. This will enable every medicine to carry a unique code that patients can scan to verify authenticity and price. Additionally, export certifications such as GMP, CoPP, and NOCs are now being processed online via the Pakistan Single Window, and all regulatory submissions are handled through the new 'e-App' online platform. Provincial Minister Khawaja Imran Nazir reaffirmed Punjab's full support for the federal government's health agenda. 'Punjab has greater capacity and resources, and we are ready to share these to benefit all provinces. The health of our people must come before all else,' he stated. He also praised DRAP's initiatives under the leadership of Minister Kamal, particularly, those targeting counterfeit pharmaceuticals. The two ministers agreed on the importance of coordinated measures to prevent dengue outbreaks in Islamabad and Rawalpindi and committed to united efforts in disease prevention, vaccination campaigns, and health system strengthening. They stressed that collaboration between federal and provincial levels is crucial to achieving meaningful progress in the health sector. Copyright Business Recorder, 2025
Business Recorder
4 days ago
- Business Recorder
Refugee camp schools at risk in Bangladesh in aid crisis
DHAKA: Global aid cuts have forced the UN children's agency to sack more than 1,000 teachers in Bangladesh camps for Rohingya refugees, with more jobs at risk without funding. Around a million members of the persecuted and mostly Muslim Rohingya live in squalid relief camps in Bangladesh, most of them after fleeing a 2017 military crackdown in neighbouring Myanmar. The teacher firings come in the wake of dramatic US funding cuts. 'Due to the global aid funding crisis, UNICEF has had to make difficult decisions impacting early education services for Rohingya refugee children,' the agency said in a statement late Tuesday. UNICEF said that the contracts of 1,179 people – working on kindergarten and primary schools – were terminated. Before the cuts, there were an estimated 4,000 teachers in the camps, according to Bangladeshi senior government aid official, Md Shamsud Douza. Schools have closed for the Muslim holiday of Eid, but if fresh funding is not secured by the time term resumes at the end of June, more teachers could lose their jobs. 'The return of the rest of the workers…depends on new funding being secured,' UNICEF added. 'We remain committed and hopeful that increased support will restore what every child deserves: a future.' UN halts plan to halve refugee rations for Rohingya in Bangladesh Humanitarian organisations worldwide have been reeling since US President Donald Trump returned to office in January, freezing most foreign aid funding. The United States has traditionally been by far the top donor to a number of agencies, which have been left scrambling to fill sudden budget gaps. 'We are deeply aware of the urgent needs faced by Rohingya refugee children, many of whom have already endured significant trauma and disruptions to their education, health, nutrition and protection,' UNICEF added. 'Our goal is to ensure they have essential skills, that they have basic qualifications that give them confidence to contribute to their communities when the time is safe for them to return.'
